Hospitals Innovation Pharma & Biotechnology Press Strategy

Major shake-ups in the ranks of the most innovative pharma

The tenth annual Pharmaceutical Innovation Index, released by IDEA Pharma today, sees Roche top the industry for the first time. At the same time, the second Pharmaceutical Invention Index, a ranking of the industry’s best pipelines, sees AstraZeneca retain its No 1 position.

The Pharmaceutical Invention Index introduces a ranking of the industry’s best pipelines, evaluating novelty and meaningful development, across first in class development, breakthrough medicines and more. Defining innovation as “return on invention,” the Pharmaceutical Innovation Index measures, scores and celebrates a company’s ability to deliver innovation to patients, by objectively evaluating performance based on a rolling five year period (2014-2019), and operates on the simple premise: if you gave the same molecule to two different companies in early phase, which would make the best of it?

Combined 2020 Pharmaceutical Innovation and Invention Indices

Roche’s significant rise to No 1 on the Innovation Index can be attributed to multiple clinical data wins, a pair of novel FDA approvals and many path-leading immuno-oncology firsts by the company’s PD-L1, Tecentriq. The Innovation Index top 10 includes new players – Vertex, Alexion and Shionogi – as well as a significant rise for Regeneron, suggesting that smaller companies are, more than ever, able to bring their products to patients without a traditional large pharma partner. AstraZeneca’s retention of the Invention Index No 1 reveals the success of their relentless focus on pipeline diversity and novelty.

Pharmaceutical Innovation Index 2020

Company Name2020 Pharmaceutical
Innovation Index
Change from 2019
Roche1+7
AbbVie20
Novartis3+6
Vertex Pharmaceuticals3New
Eli Lilly5-2
AstraZeneca6+6
Alexion Pharmaceuticals7New
Merck & Co8-3
Shionogi & Co9New
Johnson & Johnson10+1
Regeneron Pharmaceuticals10+7

Pharmaceutical Invention Index 2020

Companies2020 Pharmaceutical
Invention Index
Change from 2019
AstraZeneca10
Bristol-Myers Squibb2+4
Eli Lilly30
Novartis40
Gilead Sciences5+6
Regeneron Pharmaceuticals6+1
AbbVie7-2
Merck & Co7+8
Vertex Pharmaceuticals9-4
Roche10+2

Commenting on the index, IDEA Pharma’s CEO, Mike Rea said: “There is no gaming the Pharmaceutical Innovation Index –success is achieved by discovering and developing meaningfully great medicines and getting those medicines to market, and to patients. More than ever, we see that excellence is unevenly distributed across the industry – not every company is equally able to realise the value in their pipeline.”

Meeta Ramnani
Meeta Ramnani
Meeta develops credible content about various markets based on deep research, opinions from experts and inputs from industry leaders. As the managing editor at Smart Industry News, she assures that every piece of news and article adds to the knowledge of decision makers. An avid bike rider, Meeta, is a postgraduate from Indian Institute of Journalism and New Media (IIJNM) Bangalore, where her specialization was Business Journalism. She carries experience from mainstream print media including The Times Group and Sakal Media Group.
https://smarthealthcarenews.com/